P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE

• M Mateos,
• X Leleu,
• E Zamagni,
• M Delforge,
• S Bringhen,
• A Broijl,
• J de la Rubia,
• A Shaw,
• A Brescianini,
• S Gonzalez-McQuire,
• S Patel,
• P Moreau

Affiliations

M Mateos

1 Hospital Universitario de Salamanca, Salamanca (ES)

X Leleu

2 Poitiers University Hospital, Poitiers (FR)

E Zamagni

3 IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna (IT)

M Delforge

5 Universitair Ziekenhuis Leuven, Leuven (BE)

S Bringhen

6 AOU Città della Salute e della Scienza di Torino, Turin (IT)

A Broijl

7 Erasmus MC Kanker Instituut, Rotterdam (NL)

J de la Rubia

8 University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia, Valencia (ES)

A Shaw

9 Wickenstones Ltd, UK, Oxford (UK)

A Brescianini

10 Amgen (Europe) GmbH, Rotkreuz (CH)

S Gonzalez-McQuire

10 Amgen (Europe) GmbH, Rotkreuz (CH)

S Patel

11 Amgen Ltd, Uxbridge (UK)

P Moreau

12 Nantes University Hospital, Nantes (FR).